Gene expression is partially down-regulated in primary cell lines, and the loss of SERPINB5 expression is correlated with increasing malignancy in several tumours, such as breast14, prostate15, thyroid16 and skin17. This evidence concerns the gene SERPINB5 and neoplasm.